Table 2.
Metrics of GV | Individuals | Results | References |
---|---|---|---|
SDBG | 100 T1DM patients | A predictor of the prevalence of DPN | 1 |
MAGE | 17 T1DM patients | Strongly correlated with excitability markers of DPN | 61 |
SD and CV of HbA1c | 50 T1DM patients | Long-term GV is associated with DPN | 62 |
CV-HbA1c, M-HbA1c | 563 T2DM patients | Closely associated with DPN | 65 |
SD and CV of HbA1c | 223 T2DM patients | Strongly associated with the severity of DPN | 66 |
SD-blood glucose, MODD, and MAGE | 90 T2DM patients | MAGE is significantly correlating with DPN | 67 |
MODD, MAGE, and SD | 982 T2DM patients | Significant independent contributor to DPN | 68 |
Fasting plasma glucose -CV | 2773 T2DM patients | Significantly associated with a risk of painful DPN | 70 |
Time in range | 364 individuals with DPN | Correlated with painful DPN | 71 |
DPN diabetic peripheral neuropathy, CV coefficient of variation, SD standard deviation, T2DM type 2 diabetes mellitus, T1DM type 1 diabetes mellitus, HbA1c hemoglobin A1c, MAGE mean amplitude of glycemic excursion, MODD mean of daily differences.